Recombinant Anti-STAT6 antibody [YE361]

Key features and details

Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
Rabbit monoclonal [YE361] to STAT6
Suitable for: Flow Cyt (Intra), WB, IHC-P, ICC/IF, IP
Reacts with: Mouse, Human

Overview

Product name

Anti-STAT6 antibody [YE361]
See all STAT6 primary antibodies

Description

Rabbit monoclonal [YE361] to STAT6

Host species

Rabbit

Specificity

The antibody does not cross-react with other Stat family members.

Tested applications

Suitable for: Flow Cyt (Intra), WB, IHC-P, ICC/IF, IPmore details

Species reactivity

Reacts with: Mouse, Human

Immunogen

Synthetic peptide within Human STAT6 aa 800 to the C-terminus (C terminal). The exact sequence is proprietary.
Database link: P42226

Positive control

WB: Raji, NIH/3T3 and RAW 264.7 cell lysates. IHC-P: Human skin carcinoma, kidney, transitional cell carcinoma of bladder, glioma and solitary fibrous tumor tissues; Mouse kidney tissue. ICC/IF: HeLa cells. Flow Cyt (intra): HeLa cells. IP: NIH/3T3 cell lysate.

General notes

This product is a recombinant monoclonal antibody, which offers several advantages including:

– High batch-to-batch consistency and reproducibility

– Improved sensitivity and specificity

– Long-term security of supply

– Animal-free production

For more information see here.

Our RabMAb^® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb^® patents.

We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated ‘PUR’ on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.

Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.